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Abstract
Background: Computed Tomography (CT) is considered the gold-standard for the pre-operative evaluation of
urolithiasis. However, no Hounsfield (HU) variable capable of differentiating stone types has been clearly identified.
The aim of this study is to assess the predictive value of HU parameters on CT for determining stone composition
and outcomes in percutaneous nephrolithotomy (PCNL).
Methods: Seventy seven consecutive cases of PCNL between 2011 and 2016 were divided into 4 groups: 40 (52%)
calcium, 26 (34%) uric acid, 5 (6%) struvite and 6 (8%) cystine stones. All images were reviewed by a single urologist
using abdomen/bone windows to evaluate: stone volume, core (HUC), periphery HU and their absolute difference.
HU density (HUD) was defined as the ratio between mean HU and the stone’s largest diameter. ROC curves assessed
the predictive power of HU for determining stone composition/stone-free rate (SFR).
Results: No differences were found based on the viewing window (abdomen vs bone). Struvite stones had values
halfway between hyperdense (calcium) and low-density (cystine/uric acid) calculi for all parameters except HUD,
which was the lowest. All HU variables for medium-high density stones were greater than low-density stones (p < 0.001).
HUC differentiated the two groups (cut-off 825 HU; specificity 90.6%, sensitivity 88.9%). HUD distinguished calcium from
struvite (mean ± SD 51 ± 16 and 28 ± 12 respectively; p = 0.02) with high sensitivity (82.5%) and specificity (80%) at a
cut-off of 35 HU/mm. Multivariate analysis revealed HUD≥ 38.5 HU/mm to be an independent predictor of SFR (OR = 3.1,
p= 0.03). No relationship was found between HU values and complication rate.
Conclusions: HU parameters help predict stone composition to select patients for oral chemolysis. HUD is an
independent predictor of residual fragments after PCNL and may be fundamental to categorize it, driving the imaging
choice at follow-up.
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Background
Computed Tomography (CT) is the gold standard for
the pre-operative study of stones and influences the choice
of surgical strategy [1]. Hounsfield Units (HU) indicate
the hardness of renal calculi and identify high density
stones to be excluded from shockwave lithotripsy (SWL)
[2]. Several in vitro studies have demonstrated the utility
of CT in predicting stone composition [3–6]. The use of
different HU parameters, such as Hounsfield Density
(HUD), has been proposed to distinguish stone groups in
vivo [7–12]. In order to further improve the differentiation
of stones, scans conducted with the bone window setting
have been attempted [13] and, recently, the mean HU
value has been suggested as a predictor for the stone-free
rate (SFR) after percutaneous nephrolithotomy (PCNL)
[14]. To the best of our knowledge, no study has evaluated
the role of a wide range of HU parameters in vivo. The
aim of this study is to evaluate the clinical significance and
utility of the HU parameters determined during pre-
operative CT study, using bone and soft tissue window
(=abdomen), to be predictive factors of stone composition,
SFR and complication rate in a cohort of patients submit-
ted to PCNL.
Patients and methods
We retrospectively reviewed the institutional stone regis-
try between January 2011 and April 2016. 284 patients
submitted to PCNL were found. Inclusion criteria were: I)
the availability of a pre-operative CT-scan, II) a maximum
stone diameter > 4 mm, III) the availability at our Institution
of the biochemical analysis of the stones, IV) a prominent
stone component >50% in mixed stones. Patients with
pre-operative urinary stents were excluded.
CT scans were performed with a 64-detector row
Lightspeed VCT scanner (General Electric Healthcare,
Milwaukee, WI) with tube voltage 120 kV, energy >100 mA,
pitch 1:1, slice thickness comprised between 0.6 and 5 mm.
CT scans were evaluated by the same Urologist (M.D.),
blinded to the stone composition, using PACS Synapse
Fujifilm version 4.0 software at 4× zoom. Both bone (XB)
and soft tissue (XST) windows were analyzed. The slice with
the stone’s largest diameter (D1) on the axial plane was
selected and the following variables were recorded: perpen-
dicular diameter (D2), HU value at the center of the stone
(HUC) and the mean HU value (HUM) which was calcu-
lated by generating an extensive circular Region Of Interest
(ROI). The HU value at the stone’s periphery (HUP) was
obtained from the mean of HU values at extremities of D1
and D2 (Fig. 1). HUD was defined as the ratio between
HUM and D1. The absolute HU difference between the
stone center and periphery was calculated as HUC minus
HUP (ΔHU). The stone’s Area (A) and Volume (V) were
estimated using Tiselius formulas [15]. D3 was determined
as the maximum diameter at coronal plane CT scans.
PCNL was performed by the same surgeon (E.M.) for
all cases. The procedure was conducted in the supine
position. An open-ended ureteral catheter was positioned
before an ultrasound-guided renal puncture. A one-shot
dilatation of the percutaneous access tract was conducted
using an Amplatz 24 Charrier dilator [16]. Lithotripsy was
performed with ballistic, ultrasound or holmium laser
energy while fragments were removed with an endoscopic
nipper or basket. An 8 Ch nephrostomy was positioned at
the conclusion of each procedure.
The evaluated peri-operative parameters were surgical
time (from the access puncture to nephrostomy), reduction
of hemoglobin, fever, need for transfusion and hospital stay.
Complications were classified using the Clavien-Dindo
score modified by the Clinical Research Office of Endouro-
logical Society (CROES) and divided in three groups:
no complications, slight complications (Clavien-Dindo
1/2), severe complications (Clavien-Dindo ≥3) [17].
SFR, defined as the absence of residual fragments, was
assessed by US or CT after 3 months. Stone composition
was determined by infrared spectrophotometry (Thermo
Scientific Nicolet™ iS™ 10) and stones were categorized
into 4 groups: 40 (52%) calcium, 26 (34%) uric acid, 6
(8%) cystine and 5 (6%) struvite. The patient group was
composed of 52 (67%) men and 25 (33%) women with a
mean age of 57 (range 14–92) years. No differences in
terms of sex and age were found between stone com-
position groups, with the exception of patients with
cystine stones who had a younger average age (32 years)
(Additional file 1: Table S1).
Statistical analysis was performed utilizing GraphPad
Prism v 5 (GraphPad Software Inc., California, USA) and
SPSS v 13.0 (IBM Cor., Armonk, NY, USA). T-tests and
one-way analysis of variance (ANOVA) tests were used
for group comparisons. Chi-Square and logistic regressions
were calculated for categorical parameters. Receiver Oper-
ating Characteristic (ROC) curves were generated to find
HU value cut-offs (defined as Youden J Index) to predict
stone composition and SFR. Statistically significant differ-
ences were assumed for p values less than 0.05.
Results
Analysis of the groups showed that stone dimensions
appeared generally larger using the CT soft tissue window,
but no significant differences in D1, A and V were observed.
On the contrary, HU values were higher using the CT bone
window (Table 1).
Comparisons were made between the stone groups on
the results obtained for 4 variables (HUM, ΔHU, HUC,
HUD) using both the bone and soft tissue windows.
Calcium stones were consistently hyperdense while uric acid
and cystine stones had lower HU values. Struvite had inter-
mediate values on all variables with the exception of HUD,
which was the lowest among all stone groups (Fig. 2).
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Fig. 1 Calculus of left renal pelvis (a). Maximum/perpendicular diameters and ROI of the stone on soft tissue (b, c) and bone (d, e) window scans.
Legend: A = area; P = perimeter; M =mean Hounsfield; SD = standard deviation
Table 1 Stone characteristics on soft tissue/bone window CT (mean ± SD)
Soft tissue (Bone)
windows
p Calcium Uric acid Cystine Struvite
D1 (mm) 19 ± 7 (17 ± 7) 0.34 18 ± 6 (16 ± 6) 19 ± 8 (18 ± 8) 18 ± 8 (17 ± 8) 24 ± 6 (23 ± 6)
Area (mm2) 188 ± 137 (164 ± 126) 0.26 174 ± 122 (148 ± 111) 190 ± 150 (168 ± 137) 204 ± 168 (185 ± 160) 275 ± 152 (250 ± 143)
Volume
(mm3)
2914 ± 3481
(2438 ± 3084)
0.37 2495 ± 3072
(2024 ± 2669)
3097 ± 4034
(2612 ± 3563)
4178 ± 4228
(3714 ± 3964)
3792 ± 2964
(3318 ± 2637)
HUC 942 ± 378 (986 ± 389) 0.48 1190 ± 251 (1240 ± 259) 606 ± 276 (638 ± 271) 683 ± 75 (708 ± 66) 1010 ± 394 (1090 ± 439)
HUP 314 ± 55 (395 ± 93) <0.001 330 ± 59 (426 ± 85)a 287 ± 41 (358 ± 98)a 300 ± 45 (358 ± 49) 340 ± 42 (390 ± 96)
HUM 687 ± 265 (761 ± 306) 0.11 835 ± 233 (941 ± 270) 500 ± 203 (531 ± 216) 542 ± 86 (608 ± 86) 650 ± 235 (700 ± 255)
ΔHU 628 ± 356 (590 ± 347) 0.5 860 ± 234 (814 ± 245) 319 ± 266 (280 ± 216) 383 ± 75 (350 ± 45) 670 ± 411 (700 ± 434)
HUD 41 ± 19 (50 ± 26) 0.01 51 ± 16 (63 ± 22)a 31 ± 18 (36 ± 22) 35 ± 14 (43 ± 21) 28 ± 12 (33 ± 16)
a Significant difference (p ≤ 0.01) between HU values at soft tissue versus bone windows
Legend: D1 = stone’s largest diameter at axial plane; HUC = HU at the center; HUP = HU value at periphery; HUM = HU mean value; ΔHU = HUC-HUP; HUD = ratio
between HUM and D1
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The mean values for calcium stones differed from those
of the uric acid calculi on every parameter considered
while cystine stones did not differentiate from struvite/
uric acid calculi.
The values for HUC, HUM and ΔHU, but not HUD,
differed between calcium and cystine stones. Struvite
calculi had significantly higher values than uric acid stones
for HUC and ΔHU, with ΔHUB being the parameter that
best differentiated them (mean ± SD 700 ± 434 vs 280 ±
216; p = 0.004).
Calcium and struvite stones differed significantly for
HUDST (mean ± SD 51 ± 16 and 28 ± 12 respectively; p =
0.02). For a HUDST cut-off of 35 HU/mm, sensitivity was
82.5%, specificity 80%, negative predictive value (NPV)
36% and positive predictive value (PPV) 97%.
In order to apply these results in a clinical setting we
grouped hypodense stones (uric acid, cystine) and com-
pared them with hyperdense stones (calcium, struvite),
finding that the hypodense had statistically lower HU
values (p < 0.001). HUCST more accurately differentiated
the two groups with a specificity of 90.6%, sensitivity
88.9%, PPV 93% and NPV 85.3% at a cut-off of 825 HU
(Additional file 2: Figure S1).
Mean surgical time was 123 (40–240) minutes, medium
hospital stay was 6 (1–15) days. Linear regression revealed
that hospital stay was inversely correlated with HUDST (p =
0.04) and HUDB (p = 0.02).
In 42 (55%) patients no complications were recorded,
in 24 (32%) and 11 (13%) Clavien-Dindo grade 1–2 and
grade ≥ 3 complications were observed, respectively. A
hemoglobin drop necessitating blood transfusion was
observed in 6 (7.8%) cases. HUD values in patients
requiring transfusion, irrespective of the window used,
were generally higher (mean HUDST 54.89 ± 10.58 vs.
40.13 ± 2.14, p = 0.06; mean HUDB 69.78 ± 14.63 vs
48.6 ± 2.86, p = 0.05). The other evaluated peri-operative
data were not related to HU values. SFR was 61% with no
differences according to stone composition (p = 0.37).
However, SFR was significantly higher in patients with
stones <2 cm compared to those with stones deemed to
be ≥2 cm using soft tissue (71% vs 40%; p < 0.009) and
bone scans (70% vs 42%; p < 0.01). To evaluate whether an
HU parameter was predictive of SFR we analyzed each
variable, generating ROC curves. HUDST (cut-off 38.5
HU/mm) was the best SFR predictive factor (AUC 0.66,
sensitivity 70%, specificity 63.8%, OR 4.12, p = 0.005;
Table 2). Multivariate analysis revealed HUDST to be a
significant predictor of SFR regardless of stone diameter
(OR = 3.1, p = 0.03).
Discussion
The current study evaluates the clinical applications of
HU characterization using bone and soft tissue window
CT scans in a cohort of patients treated with PCNL.
At present, there is no proven method to differentiate
stone types prior to endosurgery or SWL. However, the
treatment choice for intrarenal stones is based on stone
dimension, location and HUM [18].
Mostafavi et al. has shown the predictive value of HU
obtained from CT scans to differentiate uric acid, struvite
and calcium oxalate kidney stones, while Dual-Energy CT
has been proposed, albeit with controversial results, to
Fig. 2 Visual distribution of HUC (1a), HUM (1b), ΔHU (1c), HUD (1d) evaluated in soft tissue (●) and bone (○) scans for all stone types. Legend:
HUC = HU at the center of the stone; HUM = HU mean value; ΔHU = difference between HUC and HU at stone’s periphery; HUD = ratio between
HUM and stone’s largest diameter at axial plane
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improve HU power to predict stone composition [5, 9, 19].
However, this procedure is impractical as it is not avail-
able in the majority of the hospitals.
Eisner et al. explored the precision of bone and abdo-
men window scans in measuring ureteral stones that
were then spontaneously passed and physically mea-
sured. They concluded that the bone window offers a
substantially more accurate estimate than the abdomen
window [13]. Our study shows that stone diameter is
smaller and HU values are higher when observed with
the bone window, probably due to the better contrast
provided by this window. However, such differences are
clinically irrelevant.
Torricelli et al. analyzed the predictive power of HUC
to differentiate uric acid (n = 47), calcium oxalate (n = 36)
and cystine (n = 30) stones and concluded that HUC of
calcium oxalate stones is significantly higher than that of
uric acid stones [11]. Two studies have explored the possi-
bility of dividing the HU value by the stone’s maximum
diameter to reduce the bias derived from the observation
that the bigger the stone, the higher the HU, regardless of
the type of calculi. Nakada et al. reported the utility of the
maximum HU/size ratio in discriminating uric acid versus
calcium stones (28.8 ± 27.2 vs 49.1 ± 85.2; p = 0.0001) in a
cohort of 99 patients [7].
Motley et al. confirmed the utility of the HU/size ratio
(HUD), showing that it discriminated calcium (n = 87;
mean ± SD = 105 ± 43), uric acid (n = 7; 50 ± 24), cystine
(n = 2; 45 ± 4) and struvite (n = 4; 53 ± 28) stones [8].
Our study further confirms the capability of HU parame-
ters to differentiate uric acid and cystine stones from cal-
cium stones, regardless of the type of HU variable analyzed.
Uric acid calculi have lower ΔHU and HUC values than
struvite stones, while cystine calculi have HU values similar
to stones composed of uric acid and struvite. However, the
diagnosis of cystine stones is also guided by laboratory and
epidemiological data (Brand’s test, urinary pH, crystals,
uricosuria, uricemia, patient age).
HU measurements are useful if they first provide
differentiation of medium-high (calcium, struvite) from
low dense (uric acid, cystine) stones and then distinguish
calcium from struvite stones. HUCST is the best predictor
of stone density at a cut-off of 825 HU with a PPV of 93%
and a NPV of 85.3%. Our study also demonstrates that
struvite has low HUD, which differentiates it from calcium
with a high sensitivity (82.5%) and specificity (80%).
These results suggest the utility of creating a flow-chart
based on HUC and HUD values with integrated laboratory
and demographic data to pre-operatively recognize stone
composition (Fig. 3). The possibility to characterize uric
Table 2 Specificity and sensitivity of HUD in predicting stone-free rate at 3 months and relative univariate analysis
ROC curve Stone free Univariate analysis
Cut-off AUC Sens Spec p no (%) yes (%) OR (95%- CI) p
HUDST <38.5 21 (55) 17 (45) 1.00 Ref
≥38.5 0.66 70% 63.8% 0.016 9 (23) 30 (77) 4.12 (1.54–10.99) 0.005
HUDB <49 21 (54) 18 (46) 1.00 Ref
≥49 0.67 70% 61% 0.015 9 (24) 29 (76) 3.76 (1.42–9.99) 0.008
Legend: HUD ratio between HU mean value and stone’s largest diameter at axial plane on soft tissue (ST) or bone (B) CT window, OR Odds ratio, CI
Confidence interval
Fig. 3 Stone composition assessment using HU values on CT. Legend: HUC = HU at the center of the stone; HUD = ratio between HU mean value
and stone’s largest diameter at axial plane
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acid stones with such accuracy may help to individuate
candidates for oral chemolysis.
HU measurements are also known to be predictive fac-
tors of SFR after PCNL as described by CROES in a cohort
of 5803 patients. Gücük et al. demonstrated that a HUM
lower than 677.5 HU is a predictor of PCNL failure, even
if the AUC was only 0.299 [14, 20]. In our study HUDST is
an independent predictor of PCNL failure when lower
than 38.5 HU/mm, indicating a 3.1 folds higher risk of
residual stones. This may be due to the low sensitivity of
intra-operative fluoroscopy in detecting stones less dense
than 500 HU as reported by Chua et al. [21]. Furthermore,
low HUD also indicates a large stone, which is one of the
best-known predictive factors of PCNL failure. HUD, eval-
uated with other data such as the number of stones, their
dimensions and the intraoperative stone clearance impres-
sion, can help categorize the risk of residual fragments.
For high risk cases, a non-contrast CT should be requested
at follow-up; otherwise an abdominal ultrasound might be
preferred.
HU values were also correlated with peri-operative
data. Our study shows that the higher the HUD, the
shorter the hospitalization time. This result is in line
with generally lower complication rates for hyperdense
calculi, as described by CROES [20]. In contrast, the
need for transfusion was directly related to HUD values,
consistent with the data of Gücük et al. who reported a
larger decrease in hemoglobin in cases of high HUM
[14]. This can be explained by the energy needed to
break hard stones into fragments, which can increase
the risk of mucosal damage.
Our study has some limitations. First, it is a retro-
spective study with relatively few patients. We did not
differentiate between calcium oxalate monohydrate and
dihydrate stones because of the limited number of patients.
Furthermore, the CT collimation varied between 0.6 and
5 mm; however, we tried to reduce this limit by only evalu-
ating stones larger than 4 mm to increase the precision of
each procedure.
For these reasons perspective studies should be conducted
to confirm the results we describe.
Conclusions
HU measurements at CT scan may help predict stone
composition, regardless of the window setting (i.e. bone or
abdomen) used. HUC accurately differentiates medium to
high (struvite, calcium) from low (uric acid, cystine) density
stones, a factor that can aid in selecting patients for oral
chemolysis, while HUD distinguishes struvite from calcium
calculi. Of note, HUD is an independent predictor of
stone-free status after PCNL at three-month follow-up.
Thus, it may be a useful tool for categorizing the risk of
residual fragments and planning imaging follow-up.
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